PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 61.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.07 | 52 Week High | $35.40 | |||
| Open | $61.07 | 52 Week Low | $4.03 | |||
| Day High | $61.07 | P/E | 6.50 | |||
| Day Low | $61.07 | EPS | $9.40 | |||
| Volume | 1,021 | |||||
